Haryana’s New Pharma Policy Set to Revolutionize Medical Manufacturing with ₹10,000 Crore Investment, ETHealthworld
New Delhi: AiMeD has come out in support of the Haryana Pharmaceutical and Medical Devices Manufacturing Policy 2026, calling it “possibly the most incentivising and progressive framework announced by any state in India.”
The policy, introduced by the Haryana government, aims to attract investments of over Rs. 10,000 crore, generate 20,000 jobs, and foster innovation in the pharmaceuticals and medical devices sectors.
The association described it as setting a new benchmark for supporting pharmaceuticals and medical devices, welcoming the policy’s “comprehensive incentives, CAPEX support of up to 30 per cent, OPEX support of up to 80 per cent, with a cap of Rs 200 crore on CAPEX and Rs 20 crore on OPEX, export-linked rewards, patent commercialisation assistance, and encouragement for green manufacturing.”
According to AiMeD, while India supplies 20 per cent of the world’s generic medicines and 60 per cent of global vaccines, it continues to rely heavily on imports for bulk drugs and high-end medical devices. It added that Haryana’s policy directly addresses this gap and is expected to promote indigenous manufacturing, research and development, and infrastructure growth.
Rajiv Nath, Forum Coordinator, AiMeD, said: “We wholeheartedly applaud Haryana’s visionary policy. It is the most incentivising framework from any progressive state, combining attractive and highly flexible CAPEX and OPEX incentives with strong support for innovation, sustainability, and exports.
He also added that it will truly unlock India’s healthcare manufacturing potential in reducing the compliance burden, urged the state and central governments to provide a three-year compliance holiday for greenfield investments and a one-year amnesty for existing units to upgrade infrastructure and align with current regulations.
“As recommended by the Rajiv Gauba Committee, arbitrary requirements such as NOCs not backed by legislation and lengthy, interdependent approval timelines must be eliminated to ensure projects move forward swiftly and confidently,” Rajiv Nath said.
Pawan Choudhary, Advisor, Chief Minister of Haryana for the Foreign Cooperation Department, said, “Haryana transforms investor interest into real opportunities. As a trusted partner for long-term economic growth, its landmark policy couples generous CAPEX and OPEX incentives with a transparent single-window system.”
“This clarity assures ease of doing business, accelerates overseas investment, and positions Haryana as a preferred global destination for medical device manufacturing,” he added.
